Resilience is proud to support CARGO Therapeutics' novel allogeneic CAR-T cell therapy
SAN CARLOS, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to...
NEWS
Read on
Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD
San Diego, CA – January 8, 2025 – National Resilience, Inc. (Resilience), a technology-driven biomanufacturing leader dedicated to broadening access...
Resilience Announces Appointment of William S. Marth, RPh., MBA as Chief Executive Officer
SAN DIEGO, CA, December 5, 2024 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening...
Resilience Secures Funding to Expand Domestic Manufacturing for Critical Pharmaceutical Ingredients
San Diego, CA – October 3, 2024 – National Resilience, Inc., a technology-focused biomanufacturing company dedicated to broadening access to complex...
Resilience Appoints Dr. Susan Billings, Chief Commercial Officer
SAN DIEGO, CA, September 30, 2024 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening...
Meet The 24 Biotech Startups That Top VCs Say Are Poised To Take Off In The next 12 Months
Insider asked 12 top VCs to name biotech startups poised to take off in the next 12 months. These startups are revolutionizing manufacturing,...
